M. Vanaclocha

Participation and detection rates by age and sex for colonoscopy versus fecal immunochemical testing in colorectal cancer screening

Á. Lanas, J. Cubiella, D. Salas, 2014, Cancer Causes & Control.

PCA3 as a second-line biomarker in a prospective controlled randomized opportunistic prostate cancer screening programme

J. López-Guerrero, A. Molina, J. Casanova, 2017 .

Informed participation in the Valencian Community Colorectal Cancer Screening Programme from a gender perspective.

R. Peiró-Pérez, D. Salas, A. Molina-Barceló, 2018, Gaceta sanitaria.

Reasons for participating in the Valencian Community Colorectal Cancer Screening Programme by gender, age, and social class.

R. Peiró-Pérez, A. Molina-Barceló, M. Vanaclocha, 2014, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

PCA3 as a second-line biomarker in a prospective controlled randomized opportunistic prostate cancer screening programme.

J. López-Guerrero, A. Molina, J. Casanova, 2017, Actas urologicas espanolas.

Participation and detection rates by age and sex for colonoscopy versus fecal immunochemical testing in colorectal cancer screening

Á. Lanas, J. Cubiella, D. Salas, 2014, Cancer Causes & Control.